New ideas for therapy in ALS

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 6, Issue 1, 2005, Pages 3-4

  Swash, Michael ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; PENICILLIN G; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN STEM; CLINICAL TRIAL; DISEASE MODEL; DRUG APPROVAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; MOTOR CORTEX; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL CORD VENTRAL HORN; SURVIVAL RATE; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; NEUROPROTECTIVE AGENTS; RILUZOLE; SUPEROXIDE DISMUTASE;

EID: 18744396928     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820510035379     Document Type: Editorial

References (2)

1. Rothstein JD, Patel S, Ryan MR, Haenggeli C, Huang YH, Bergies DE, et al. Lactam antibiotics offer neuroprotection by increasing glutamate transport expression. Nature. 2005;433:73-7.
2. Miller TM, Cleveland DW. Treating neurodegenerative diseases with antibiotics. Science. 2005;307:361-2.